Premium
Association between a functional polymorphism (‐1195T>C) in the IGFBP5 promoter and head and neck cancer risk
Author(s) -
Niu Jiangong,
Huang YuJing,
Wei Sheng,
Liu Zhensheng,
Wang LiE,
Chang Shine,
Chamberlain Robert M.,
ElNaggar Adel K.,
Sturgis Erich M.,
Wei Qingyi
Publication year - 2011
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.21514
Subject(s) - head and neck cancer , head and neck , medicine , association (psychology) , oncology , polymorphism (computer science) , genetics , cancer , biology , genotype , psychology , gene , surgery , psychotherapist
Background. To the best of our knowledge, no studies to date have evaluated roles of insulin‐like growth factor binding protein 5 ( IGFBP5 ) polymorphisms in risk of squamous cell carcinoma of the head and neck (SCCHN).Methods. A hospital‐based study of 1082 patients with SCCHN and 1120 cancer‐free controls was performed to investigate associations between 2 functional polymorphisms, ‐1195T>C and ‐709G>C, in the IGFBP5 promoter region and SCCHN risk.Results. We demonstrated that the transcription factor, activator protein 1 (AP‐1), differentially bound to T or C variants at ‐1195 in the promoter to regulate the IGFBP5 promoter activity and that the C variant genotypes were associated with deferential risk of late‐stage SCCHN, compared to the TT genotype, particularly for human papillomavirus (HPV)‐unrelated sites (adjusted odds ratio [OR], 2.21; 95% confidence interval [CI], 1.19–4.11 for CC vs TT).Conclusion. The IGFBP5 ‐1195T>C polymorphism is functional and may potentially be a biomarker for susceptibility to late‐stage SCCHN. © 2010 Wiley Periodicals, Inc. Head Neck, 2011
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom